GI Windows Announces Data from First-Ever Clinical Study on a New Non-surgical Procedure to Treat Type 2 Diabetes with Self-Assembling Magnets at Digestive Disease Week® 2016

Six-Month Data Support Incision-less Anastomosis
System’s Safety and Efficacy in Treating Type 2 Diabetes

New Therapy is First of its Kind with Endoscopic Delivery and the Promise
to Achieve Long-term Benefits  
Comparable to Metabolic Surgery 

 

West Bridgewater, Mass., May 24, 2016 — GI Windows, Inc., a clinical-stage medical device company, today announced the presentation of six-month results of the first-ever clinical study evaluating the endoscopic creation of a dual-path enteral diversion using the company’s Incision-less Anastomosis System (IAS) at Digestive Disease Week® 2016 (DDW), in San Diego, Calif. The data support the safety and efficacy of GI Windows’ IAS as a treatment option for Type 2 diabetes in obese patients.

Read More


GI Windows to Present First-Ever Clinical Series Data on a Novel Non-Surgical Procedure To Treat Type 2 Diabetes at Digestive Disease Week® 2016

Three Presentations Will Highlight the GI Windows Incision-less Anastomosis System

May 16, 2016 

WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--GI Windows, Inc., a clinical-stage medical device company, today announced that the company will debut its innovative new approach to managing Type 2 diabetes at Digestive Disease Week® 2016 (DDW), taking place May 21-24 in San Diego, Calif. The company will deliver three presentations at DDW, showcasing data and video of its Incision-less Anastomosis System (IAS). Among the highlights is a presentation on the six-month results of the first-ever clinical series evaluating the endoscopic creation of a dual-path enteral diversion using the IAS.

Read More


GI Windows and Joslin Diabetes Center Agree to a Memorandum of Understanding

BOSTON – (June 4, 2015) – GI Windows and Joslin Diabetes Center have signed a Memorandum of Understanding (MOU) formalizing their mutual commitment to explore avenues for collaboration, using the GI Windows technology to treat patients with type 2 diabetes.

This non-exclusive MOU was developed after meetings between the GI Windows’ team and Osama Hamdy, M.D., Ph.D, FACE, Medical Director of the Obesity Clinical Program at Joslin Diabetes Center and Assistant Professor of Medicine at Harvard Medical School.  The agreement is a step towards establishing a collaboration with GI Windows that aligns with Joslin’s mission of preventing, treating and curing diabetes in the world. 

Read More


STD Med, Inc. Welcomes G.I. Windows to its West Bridgewater Innovation Center

WEST BRIDGEWATER, Mass., March 17, 2014 /PRNewswire/ -- STD Med, Inc. is pleased to announce that medical device start-up company G.I. Windows, Inc. has commenced operations at our Innovation Center in West Bridgewater. Getting medical technologies to market is always a challenging endeavor; however STD Med through its Innovation Center is offering another option for start-up companies. STD Med is a 60 year-old contract manufacturing company which has reinvented itself as a multifaceted resource that med-tech entrepreneurs can utilize to cost effectively move their companies forward.

Read More


Beacon Endoscopic Announces Spin-Off Business for Incisionless Anastomosis Technology

GI Windows, an Affiliate of Beacon Endoscopic, Offers Breakthrough Technology Engineered to Treat Metabolic Disease Without the Need for Incisions.

NEWTON, MA--(Marketwire - Sep 13, 2012) - Beacon Endoscopic Corporation, an emerging GI endoscopy company, announced today a spin-off business, GI Windows, that will develop and bring to market a technology involving a series of self-assembling magnets (SAMSEN) for incisionless bypass procedures within the digestive system.

Read More


1 in 3 Americans Will Have Diabetes by 2050

 by Amanda Chan   |   October 22, 2010 03:31am ET (Reprint from Live Science)

In the United States, 1 in 3 people will have Type 2 diabetes by 2050 if current trends continue, according to a new report from the Centers for Disease Control and Prevention. The projections, released today (Oct. 22), are alarming to U.S. health officials, who say the numbers highlight the need for interventions to keep the number of new cases from climbing. Currently, 1 in 10 Americans has Type 2 diabetes. But if new cases develop as projected, its prevalence could double or triple over the next 40 years, said Ann Albright, director of the Division of Diabetes Translation at the CDC. "We can't have that, it's unsustainable," Albright told MyHealthNewsDaily.

Read More


Prevent Type 2 Diabetes

(Reprinted from: CDC. Centers for Disease Control and Prevention)

​Prevent or delay type 2 diabetes by learning your risk factors, eating right, becoming more physically active, losing a modest amount of weight, and managing stress. You can make a healthy change today.

A new year makes us think about our joys, challenges, families…and our health. As you reflect on your family's health history and changes you'd like to make in your own life, resolve to prevent or delay type 2 diabetes and prediabetes. Eating right, adding physical activity, and practicing healthy habits—these are all positive things you can do for your health right now.

Read More